| Primary |
| Metastases To Bone |
23.1% |
| Prostate Cancer |
13.1% |
| Product Used For Unknown Indication |
8.1% |
| Hypertension |
7.0% |
| Breast Cancer |
6.1% |
| Cancer Pain |
4.8% |
| Prophylaxis |
4.6% |
| Hypocalcaemia |
4.1% |
| Plasma Cell Myeloma |
3.7% |
| Bone Lesion |
3.5% |
| Constipation |
3.5% |
| Diabetes Mellitus |
2.8% |
| Large Intestine Carcinoma |
2.6% |
| Scleroderma |
2.4% |
| Osteoporosis |
2.2% |
| Dysuria |
1.7% |
| Lung Neoplasm Malignant |
1.7% |
| Multiple Myeloma |
1.7% |
| Gastric Ulcer |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
|
| Osteonecrosis Of Jaw |
33.3% |
| Hypocalcaemia |
31.0% |
| Pyrexia |
5.6% |
| Renal Impairment |
4.0% |
| Cerebral Infarction |
3.2% |
| Death |
2.4% |
| Hypercalcaemia |
2.4% |
| Interstitial Lung Disease |
2.4% |
| Atypical Femur Fracture |
1.6% |
| Bone Pain |
1.6% |
| Decreased Appetite |
1.6% |
| Drug-induced Liver Injury |
1.6% |
| Liver Disorder |
1.6% |
| Osteomyelitis |
1.6% |
| Pathological Fracture |
1.6% |
| Tetany |
1.6% |
| Acute Respiratory Distress Syndrome |
0.8% |
| Anaemia |
0.8% |
| Atypical Fracture |
0.8% |
| Bacteraemia |
0.8% |
|
| Secondary |
| Metastases To Bone |
20.2% |
| Prostate Cancer |
17.3% |
| Product Used For Unknown Indication |
8.7% |
| Hypertension |
6.9% |
| Plasma Cell Myeloma |
5.2% |
| Hypocalcaemia |
4.6% |
| Constipation |
4.0% |
| Osteoporosis |
4.0% |
| Large Intestine Carcinoma |
3.5% |
| Lung Neoplasm Malignant |
3.5% |
| Bone Lesion |
2.9% |
| Scleroderma |
2.9% |
| Diabetes Mellitus |
2.3% |
| Non-small Cell Lung Cancer |
2.3% |
| Pain |
2.3% |
| Prophylaxis |
2.3% |
| Benign Prostatic Hyperplasia |
1.7% |
| Bone Cancer Metastatic |
1.7% |
| Bone Pain |
1.7% |
| Breast Cancer |
1.7% |
|
| Osteonecrosis Of Jaw |
22.2% |
| Hypocalcaemia |
19.4% |
| Cerebral Infarction |
5.6% |
| Non-small Cell Lung Cancer |
5.6% |
| Rhabdomyolysis |
5.6% |
| Acute Respiratory Distress Syndrome |
2.8% |
| Anaemia |
2.8% |
| Blood Phosphorus Decreased |
2.8% |
| Bone Pain |
2.8% |
| Cardiogenic Shock |
2.8% |
| Interstitial Lung Disease |
2.8% |
| Liver Disorder |
2.8% |
| Metastatic Renal Cell Carcinoma |
2.8% |
| Neutropenia |
2.8% |
| Pathological Fracture |
2.8% |
| Platelet Count Decreased |
2.8% |
| Pneumonia Aspiration |
2.8% |
| Pyrexia |
2.8% |
| Renal Failure Acute |
2.8% |
| Sinusitis |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.6% |
| Prophylaxis |
15.9% |
| Metastases To Bone |
8.2% |
| Cough |
5.3% |
| Constipation |
4.8% |
| Pain |
4.8% |
| Gastritis |
3.9% |
| Prostate Cancer |
3.9% |
| Breast Cancer |
3.4% |
| Cancer Pain |
3.4% |
| Metastatic Gastric Cancer |
3.4% |
| Diabetes Mellitus |
2.4% |
| Metastases To Bone Marrow |
2.4% |
| Breast Cancer Metastatic |
1.9% |
| Insomnia |
1.9% |
| Metastatic Renal Cell Carcinoma |
1.9% |
| Plasma Cell Myeloma |
1.9% |
| Pleurodesis |
1.9% |
| Renal Cell Carcinoma |
1.9% |
| Soft Tissue Cancer |
1.9% |
|
| Neutropenia |
8.7% |
| Peritonitis |
8.7% |
| Pneumonia Aspiration |
8.7% |
| Akathisia |
4.3% |
| Hepatic Function Abnormal |
4.3% |
| Hypocalcaemia |
4.3% |
| Interstitial Lung Disease |
4.3% |
| Intestinal Obstruction |
4.3% |
| Malaise |
4.3% |
| Malnutrition |
4.3% |
| Oesophageal Candidiasis |
4.3% |
| Osteonecrosis Of Jaw |
4.3% |
| Pancreatic Carcinoma Stage I |
4.3% |
| Pneumonia |
4.3% |
| Pneumonia Bacterial |
4.3% |
| Pneumothorax |
4.3% |
| Proteinuria |
4.3% |
| Pulmonary Hypertension |
4.3% |
| Renal Cell Carcinoma |
4.3% |
| Somnolence |
4.3% |
|
| Interacting |
| Non-small Cell Lung Cancer Metastatic |
30.0% |
| Cancer Pain |
20.0% |
| Hypocalcaemia |
20.0% |
| Product Used For Unknown Indication |
20.0% |
| Gastric Ulcer |
10.0% |
|
| Myocardial Infarction |
100.0% |
|
